1 code implementation • EMNLP (NLP-COVID19) 2020 • Abdullatif Köksal, Hilal Dönmez, Rıza Özçelik, Elif Ozkirimli, Arzucan Özgür
Coronavirus Disease of 2019 (COVID-19) created dire consequences globally and triggered an intense scientific effort from different domains.
no code implementations • 26 Dec 2022 • Rıza Özçelik, Derek van Tilborg, José Jiménez-Luna, Francesca Grisoni
Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology, $\textit{e. g.}$, to predict protein structure and molecular bioactivity, plan organic synthesis, and design molecules $\textit{de novo}$.
no code implementations • 26 Oct 2022 • Asu Büşra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O. Ulgen, Nilgün Karalı, Arzucan Özgür
To this end, we build a language-inspired pipeline that treats high affinity ligands of protein targets as documents and selects key chemical words making up those ligands based on tf-idf weighting.
3 code implementations • 4 Jul 2021 • Rıza Özçelik, Alperen Bağ, Berk Atıl, Melih Barsbey, Arzucan Özgür, Elif Özkırımlı
Here, we present DebiasedDTA, a novel drug-target affinity (DTA) prediction model training framework that addresses dataset biases to improve the generalizability of affinity prediction models.
no code implementations • 5 Sep 2020 • Abdullatif Köksal, Hilal Dönmez, Rıza Özçelik, Elif Ozkirimli, Arzucan Özgür
Coronavirus Disease of 2019 (COVID-19) created dire consequences globally and triggered an intense scientific effort from different domains.
1 code implementation • EMNLP 2020 • Emrah Budur, Rıza Özçelik, Tunga Güngör, Christopher Potts
In this paper, we offer a positive response for natural language inference (NLI) in Turkish.
1 code implementation • 2 Nov 2018 • Rıza Özçelik, Hakime Öztürk, Arzucan Özgür, Elif Ozkirimli
Our aim is to process the patterns in SMILES as a language to predict protein-ligand affinity, even when we cannot infer the function from the sequence.